Cargando…
Single-Port Robotic-Assisted Adrenalectomy: Feasibility, Safety, and Cost-Effectiveness
BACKGROUND AND OBJECTIVES: The introduction of robotic surgery offers patients and surgeons new options for adrenalectomy. Whereas multiport adrenalectomies have been safely performed using the robot, we describe our experience with the novel technique of single-port robotic-assisted adrenalectomy....
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Society of Laparoendoscopic Surgeons
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4376215/ https://www.ncbi.nlm.nih.gov/pubmed/25848182 http://dx.doi.org/10.4293/JSLS.2014.00218 |
_version_ | 1782363706215104512 |
---|---|
author | Arghami, Arman Dy, Benzon M. Bingener, Juliane Osborn, John Richards, Melanie L. |
author_facet | Arghami, Arman Dy, Benzon M. Bingener, Juliane Osborn, John Richards, Melanie L. |
author_sort | Arghami, Arman |
collection | PubMed |
description | BACKGROUND AND OBJECTIVES: The introduction of robotic surgery offers patients and surgeons new options for adrenalectomy. Whereas multiport adrenalectomies have been safely performed using the robot, we describe our experience with the novel technique of single-port robotic-assisted adrenalectomy. METHODS: We performed a matched-cohort study comparing 16 single-port robotic-assisted adrenalectomies with 16 patients from a pool of 148 laparoscopic adrenalectomies, matched for age, gender, operative side, pathology, and body mass index. All were operated on by 1 surgeon. RESULTS: The pathology included aldosteronoma in 44% of patients, adrenocorticotropic hormone–dependent Cushing syndrome (bilateral adrenalectomy) in 19%, pheochromocytoma in 13%, and other pathology in 24%. The operative time was 183 ± 33 minutes for single-port robotic-assisted adrenalectomy and 173 ± 40 minutes for laparoscopic adrenalectomy (P = .58). The total time in the operating room was 246 ± 33 minutes for single-port robotic-assisted adrenalectomy and 240 ± 39 minutes for laparoscopic adrenalectomy (P = .57). There was 1 conversion to open adrenalectomy (6%) in each group, both because of bleeding on the right side during bilateral adrenalectomy. Two right-sided single-port robotic-assisted adrenalectomy patients required conversion to laparoscopic adrenalectomy, one because of poor visualization. There were no deaths. Complications occurred in 2 patients in each group (intensive care unit admission, prolonged ileus). Both groups had similar pain scores (mean of 3.7 on a scale from 1 to 10) on postoperative day 1, and patients in the single-port robotic-assisted adrenalectomy group used less narcotic pain medication in the first 24 hours after surgery (43 mg vs 84 mg in laparoscopic adrenalectomy group, P < .001). The differences between the single-port robotic-assisted adrenalectomy group and laparoscopic adrenalectomy group in length of stay (2.3 ± 0.5 days vs 3.1 ± 0.9 days, P = .23), percentage of patients discharged on postoperative day 1 (56% vs 31%, P = .10), and hospital cost (16% lower in single-port robotic-assisted adrenalectomy group, P = .17) did not reach statistical significance. CONCLUSION: Single-port robotic adrenalectomy is feasible; patients require less narcotic pain medication whereas costs appear equivalent compared with laparoscopic adrenalectomy. |
format | Online Article Text |
id | pubmed-4376215 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Society of Laparoendoscopic Surgeons |
record_format | MEDLINE/PubMed |
spelling | pubmed-43762152015-04-06 Single-Port Robotic-Assisted Adrenalectomy: Feasibility, Safety, and Cost-Effectiveness Arghami, Arman Dy, Benzon M. Bingener, Juliane Osborn, John Richards, Melanie L. JSLS Scientific Papers BACKGROUND AND OBJECTIVES: The introduction of robotic surgery offers patients and surgeons new options for adrenalectomy. Whereas multiport adrenalectomies have been safely performed using the robot, we describe our experience with the novel technique of single-port robotic-assisted adrenalectomy. METHODS: We performed a matched-cohort study comparing 16 single-port robotic-assisted adrenalectomies with 16 patients from a pool of 148 laparoscopic adrenalectomies, matched for age, gender, operative side, pathology, and body mass index. All were operated on by 1 surgeon. RESULTS: The pathology included aldosteronoma in 44% of patients, adrenocorticotropic hormone–dependent Cushing syndrome (bilateral adrenalectomy) in 19%, pheochromocytoma in 13%, and other pathology in 24%. The operative time was 183 ± 33 minutes for single-port robotic-assisted adrenalectomy and 173 ± 40 minutes for laparoscopic adrenalectomy (P = .58). The total time in the operating room was 246 ± 33 minutes for single-port robotic-assisted adrenalectomy and 240 ± 39 minutes for laparoscopic adrenalectomy (P = .57). There was 1 conversion to open adrenalectomy (6%) in each group, both because of bleeding on the right side during bilateral adrenalectomy. Two right-sided single-port robotic-assisted adrenalectomy patients required conversion to laparoscopic adrenalectomy, one because of poor visualization. There were no deaths. Complications occurred in 2 patients in each group (intensive care unit admission, prolonged ileus). Both groups had similar pain scores (mean of 3.7 on a scale from 1 to 10) on postoperative day 1, and patients in the single-port robotic-assisted adrenalectomy group used less narcotic pain medication in the first 24 hours after surgery (43 mg vs 84 mg in laparoscopic adrenalectomy group, P < .001). The differences between the single-port robotic-assisted adrenalectomy group and laparoscopic adrenalectomy group in length of stay (2.3 ± 0.5 days vs 3.1 ± 0.9 days, P = .23), percentage of patients discharged on postoperative day 1 (56% vs 31%, P = .10), and hospital cost (16% lower in single-port robotic-assisted adrenalectomy group, P = .17) did not reach statistical significance. CONCLUSION: Single-port robotic adrenalectomy is feasible; patients require less narcotic pain medication whereas costs appear equivalent compared with laparoscopic adrenalectomy. Society of Laparoendoscopic Surgeons 2015 /pmc/articles/PMC4376215/ /pubmed/25848182 http://dx.doi.org/10.4293/JSLS.2014.00218 Text en © 2015 by JSLS, Journal of the Society of Laparoendoscopic Surgeons. This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives License (http://creativecommons.org/licenses/by-nc-nd/3.0/us/), which permits for noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited and is not altered in any way. |
spellingShingle | Scientific Papers Arghami, Arman Dy, Benzon M. Bingener, Juliane Osborn, John Richards, Melanie L. Single-Port Robotic-Assisted Adrenalectomy: Feasibility, Safety, and Cost-Effectiveness |
title | Single-Port Robotic-Assisted Adrenalectomy: Feasibility, Safety, and Cost-Effectiveness |
title_full | Single-Port Robotic-Assisted Adrenalectomy: Feasibility, Safety, and Cost-Effectiveness |
title_fullStr | Single-Port Robotic-Assisted Adrenalectomy: Feasibility, Safety, and Cost-Effectiveness |
title_full_unstemmed | Single-Port Robotic-Assisted Adrenalectomy: Feasibility, Safety, and Cost-Effectiveness |
title_short | Single-Port Robotic-Assisted Adrenalectomy: Feasibility, Safety, and Cost-Effectiveness |
title_sort | single-port robotic-assisted adrenalectomy: feasibility, safety, and cost-effectiveness |
topic | Scientific Papers |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4376215/ https://www.ncbi.nlm.nih.gov/pubmed/25848182 http://dx.doi.org/10.4293/JSLS.2014.00218 |
work_keys_str_mv | AT arghamiarman singleportroboticassistedadrenalectomyfeasibilitysafetyandcosteffectiveness AT dybenzonm singleportroboticassistedadrenalectomyfeasibilitysafetyandcosteffectiveness AT bingenerjuliane singleportroboticassistedadrenalectomyfeasibilitysafetyandcosteffectiveness AT osbornjohn singleportroboticassistedadrenalectomyfeasibilitysafetyandcosteffectiveness AT richardsmelaniel singleportroboticassistedadrenalectomyfeasibilitysafetyandcosteffectiveness |